MicroRNA‑423‑3p promotes glioma growth by targeting PANX2 Retraction in /10.3892/ol.2021.12833

Xu,Jing; He,Jian; Huang,He; Peng,Renjun; Xi,Jian

doi:10.3892/ol.2018.8636

MicroRNA‑423‑3p promotes glioma growth by targeting PANX2

Retraction in: /10.3892/ol.2021.12833

Authors:
- Jing Xu
- Jian He
- He Huang
- Renjun Peng
- Jian Xi
View Affiliations

Affiliations: Department of Otolaryngology, Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: May 4, 2018 https://doi.org/10.3892/ol.2018.8636
Pages: 179-188
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previously, a number of microRNAs (miRs) have been identified to participate in the development and progression of glioma via the regulation of their target genes. However, the molecular mechanisms underlying the effect of miR‑423‑3p in glioma growth remain unclear. In the present study, the reverse transcription‑quantitative polymerase chain reaction and western blotting were used to assess the mRNA and protein expression levels of miR‑423‑3p, respectively. An MTT assay and flow cytometry were performed to determine cell proliferation and apoptosis, respectively. A luciferase reporter gene assay was performed to determine the target association between pannexin 2 (PANX2) and miR‑423‑3p. It was revealed that miR‑423‑3p was significantly upregulated in glioma tissues compared with normal brain tissues, and the increased expression of miR‑423‑3p was significantly associated with an advanced grade as well as a poorer prognosis of patients with glioma. Inhibition of miR‑423‑3p using an miR‑423‑3p inhibitor resulted in the decreased proliferation of glioma U251 and U87MG Uppsala cells, and the induction of apoptosis. PANX2 was identified as a novel target gene of miR‑423‑3p, and the expression of PANX2 was revealed to be increased in U251 and U87MG Uppsala cells when miR‑423‑3p was inhibited. Knockdown of PANX2 attenuated the effects of miR‑423‑3p inhibition on glioma cell proliferation and apoptosis. Furthermore, PANX2 was significantly downregulated in glioma tissues compared with normal brain tissues, and its levels were markedly lower in World Health Organization (WHO) stage III‑IV gliomas compared with WHO stage I‑II gliomas. Additionally, the expression levels of PANX2 were identified to be inversely correlated with miR‑423‑3p expression levels in glioma tissues. Consequently, targeting miR‑423‑3p may inhibit glioma growth via the upregulation of PANX2.

View Figures

View References

1	Goodenberger ML and Jenkins RB: Genetics of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
2	Yan Y and Jiang Y: RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway. Int J Mol Med. 37:251–257. 2016. View Article : Google Scholar : PubMed/NCBI
3	Marumoto T and Saya H: Molecular biology of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
4	Zhang R, Wang R, Chen Q and Chang H: Inhibition of autophagy using 3-methyladenine increases cisplatininduced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells. Mol Med Rep. 12:1727–1732. 2015. View Article : Google Scholar : PubMed/NCBI
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
7	Zheng K, Liu W, Liu Y, Jiang C and Qian Q: Microrna-133a suppresses colorectal cancer cell invasion by targeting fascin1. Oncol Lett. 9:869–874. 2015. View Article : Google Scholar : PubMed/NCBI
8	Liang ML, Hsieh TH, Ng KH, Tsai YN, Tsai CF, Chao ME, Liu DJ, Chu SS, Chen W, Liu YR, et al: Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas. Oncotarget. 7:19723–19737. 2016. View Article : Google Scholar : PubMed/NCBI
9	Xu J, Xu W and Zhu J: Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression. Mol Med Rep. 12:4815–4820. 2015. View Article : Google Scholar : PubMed/NCBI
10	Liu C, Liang S, Xiao S, Lin Q, Chen X, Wu Y and Fu J: MicroRNA-27b inhibits Spry2 expression and promotes cell invasion in glioma U251 cells. Oncol Lett. 9:1393–1397. 2015. View Article : Google Scholar : PubMed/NCBI
11	Wang H, Tao T, Yan W, Feng Y, Wang Y, Cai J, You Y, Jiang T and Jiang C: Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma. Sci Rep. 5:130722015. View Article : Google Scholar : PubMed/NCBI
12	McDaneld TG, Smith TP, Doumit ME, Miles JR, Coutinho LL, Sonstegard TS, Matukumalli LK, Nonneman DJ and Wiedmann RT: MicroRNA transcriptome profiles during swine skeletal muscle development. BMC Genomics. 10:772009. View Article : Google Scholar : PubMed/NCBI
13	Prats-Puig A, Ortega FJ, Mercader JM, Moreno-Navarrete JM, Moreno M, Bonet N, Ricart W, López-Bermejo A and Fernández-Real JM: Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab. 98:E1655–E1660. 2013. View Article : Google Scholar : PubMed/NCBI
14	Kumarswamy R, Anker SD and Thum T: MicroRNAs as circulating biomarkers for heart failure: Questions about MiR-423-5p. Circ Res. 106:e82010. View Article : Google Scholar : PubMed/NCBI
15	Oak SR, Murray L, Herath A, Sleeman M, Anderson I, Joshi AD, Coelho AL, Flaherty KR, Toews GB, Knight D, et al: A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One. 6:e212532011. View Article : Google Scholar : PubMed/NCBI
16	Xiao B, Wang Y, Li W, Baker M, Guo J, Corbet K, Tsalik EL, Li QJ, Palmer SM, Woods CW, et al: Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. Blood. 122:3365–3375. 2013. View Article : Google Scholar : PubMed/NCBI
17	Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, et al: Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010. View Article : Google Scholar : PubMed/NCBI
18	Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L, Tian Q, Zha R, Zhan R and He X: MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis. 32:1641–1647. 2011. View Article : Google Scholar : PubMed/NCBI
19	Zhao H, Gao A, Zhang Z, Tian R, Luo A, Li M, Zhao D, Fu L, Fu L, Dong JT and Zhu Z: Genetic analysis and preliminary function study of miR-423 in breast cancer. Tumour Biol. 36:4763–4771. 2015. View Article : Google Scholar : PubMed/NCBI
20	Li S, Zeng A, Hu Q, Yan W, Liu Y and You Y: miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro Oncol. 19:55–65. 2017. View Article : Google Scholar : PubMed/NCBI
21	Arocho A, Chen B, Ladanyi M and Pan Q: Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
22	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
23	Guan G, Zhang D, Zheng Y, Wen L, Yu D, Lu Y and Zhao Y: microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma. Int J Clin Exp Pathol. 7:5683–5691. 2014.PubMed/NCBI
24	Li HT, Zhang H, Chen Y, Liu XF and Qian J: MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1 in colorectal cancer. Cell Physiol Biochem. 37:1044–1054. 2015. View Article : Google Scholar : PubMed/NCBI
25	Tang W, Ahmad S, Shestopalov VI and Lin X: Pannexins are new molecular candidates for assembling gap junctions in the cochlea. Neuroreport. 19:1253–1257. 2008. View Article : Google Scholar : PubMed/NCBI
26	Swayne LA and Bennett SA: Connexins and pannexins in neuronal development and adult neurogenesis. BMC Cell Biol. 17 Suppl 1:S102016. View Article : Google Scholar
27	Swayne LA, Sorbara CD and Bennett SA: Pannexin 2 is expressed by postnatal hippocampal neural progenitors and modulates neuronal commitment. J Biol Chem. 285:24977–24986. 2010. View Article : Google Scholar : PubMed/NCBI
28	Penuela S, Harland L, Simek J and Laird DW: Pannexin channels and their links to human disease. Biochem J. 461:371–381. 2014. View Article : Google Scholar : PubMed/NCBI
29	Lai CP, Bechberger JF and Naus CC: Pannexin2 as a novel growth regulator in C6 glioma cells. Oncogene. 28:4402–4408. 2009. View Article : Google Scholar : PubMed/NCBI